Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial
A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial.
Pediatric multiple sclerosis.
Emerging roles of endothelial cells in multiple sclerosis pathophysiology and therapy.
Gut microbiota composition and relapse risk in pediatric MS: A pilot study.
Effects of murine and human bone marrow-derived mesenchymal stem cells on cuprizone induced demyelination.
Gait variability measures reveal differences between multiple sclerosis patients and healthy controls.
Assessment of statistical significance and clinical relevance.
Cytotoxicity, DNA cross-linking, and single strand breaks induced by activated cyclophosphamide and acrolein in human leukemia cells.
The Stigma Scale for Chronic Illnesses 8-Item Version (SSCI-8): Development, Validation and Use Across Neurological Conditions.
Current recommendations for multiple sclerosis treatment in pregnancy and puerperium.
Prospective memory, emotional valence, and multiple sclerosis.
Effect of rituximab on the peripheral blood and cerebrospinal fluid B cells in patients with primary progressive multiple sclerosis.
Effects of rituximab on lymphocytes in multiple sclerosis and neuromyelitis optica.
No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT.
Novel immunosuppressive strategies for bone marrow failure syndromes: a focus on alemtuzumab.
Ozanimod (RPC1063) is a potent sphingosine-1-phosphate receptor-1 (S1P1R ) and receptor-5 (S1P5R ) agonist with autoimmune disease-modifying activity.
Rituximab in Steroid-Dependent or Frequently Relapsing Idiopathic Nephrotic Syndrome.
A complex role of herpes viruses in the disease process of multiple sclerosis.
Activation of axonal Kv7 channels in human peripheral nerve by flupirtine but not placebo - therapeutic potential for peripheral neuropathies: results of a randomised controlled trial.
Subclinical CNS Inflammation as Response to a Myelin Antigen in Humanized Mice.
Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE.
White matter astrocytes in health and disease.
Normal-appearing white matter in multiple sclerosis is in a subtle balance between inflammation and neuroprotection.
A high-density screen for linkage in multiple sclerosis.

Pages